
Estracit Capsules 140 mg (Estramustine Phosphate Sodium Hydrate)
156.7mg
Hard capsule · Prescription medication
Pfizer Korea Pharmaceuticals Ltd.
Estramustine phosphate sodium hydrate is an antineoplastic agent used in the treatment of prostate cancer.
MFDS ingredient code M257238
Estramustine phosphate sodium hydrate is an antineoplastic agent primarily used for the treatment of prostate cancer. This ingredient is a compound that combines estrogen and anticancer effects, included in pharmaceuticals for the purpose of inhibiting the growth of cancer cells.
This ingredient interferes with the cell division of cancer cells, slowing the growth of tumors. It also regulates hormonal activity to inhibit the proliferation of prostate cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Estramustine phosphate sodium hydrate has a unique structure that combines an estrogen derivative and an anticancer agent, simultaneously exhibiting both actions, which results in specialized efficacy for the treatment of prostate cancer.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.